Normoglycemia restores beta-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia

Normoglycemia restores beta-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia. V Nacher , J F Merino , M Raurell , J Soler and E Montanya Endocrine Unit, Ciutat Sanitària i Universitària de Bellvitge, Barcelona, Spain. Abstract We studied the effects of chr...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 47; no. 2; pp. 192 - 196
Main Authors Nacher, V., Merino, J. F., Raurell, M., Soler, J., Montanya, E.
Format Journal Article
LanguageEnglish
Published American Diabetes Association 01.02.1998
Online AccessGet full text

Cover

Loading…
More Information
Summary:Normoglycemia restores beta-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia. V Nacher , J F Merino , M Raurell , J Soler and E Montanya Endocrine Unit, Ciutat Sanitària i Universitària de Bellvitge, Barcelona, Spain. Abstract We studied the effects of chronic hyperglycemia on beta-cell replication and mass in transplanted (Tx) islets. Five groups of streptozocin-induced diabetic C57Bl/6 mice were transplanted with 100 (Tx-100) syngeneic islets, an insufficient beta-cell mass to restore normoglycemia. Groups 1 and 2 remained hyperglycemic throughout the study; after 30 days of hyperglycemia, a second transplantation of 250 islets (Tx-250) restored normoglycemia in groups 3, 4, and 5. Tx-250 was harvested on day 60 in all three groups, and transient mild hyperglycemia developed (10-12 days); thereafter, Tx-100 maintained blood glucose values in the normal range. Tx-100 was harvested 14 (group 1), 60 (groups 2 and 3), 74 (group 4), and 90 (group 5) days after transplantation. Hyperglycemia increased beta-cell replication after 14 days (group 1: 1.26 +/- 0.18%, P < 0.05) but not after 60 days (group 2: 0.59 +/- 0.13%) compared with islets exposed to normoglycemia (group 3: 0.51 +/- 0.07%) (analysis of variance [ANOVA], P < 0.0002). beta-cell replication in group 4 increased after Tx-250 harvesting (0.94 +/- 0.16%, P < 0.05). The initially Tx beta-cell mass (0.21 +/- 0.014 mg) was progressively reduced in hyperglycemic groups (group 1: 0.13 +/- 0.020 mg; group 2: 0.048 +/- 0.012 mg; P < 0.05) (ANOVA, P = 0.0001). Restoration of normoglycemia after Tx-250 did not modify beta-cell mass in Tx-100 grafts (group 3: 0.076 +/- 0.008 mg). However, after Tx-250 harvesting, beta-cell mass increased progressively (group 4: 0.11 +/- 0.018 mg; group 5: 0.14 +/- 0.026 mg, P < 0.05), although it was still reduced compared with the initially Tx beta-cell mass (P < 0.05). In summary, Tx islets exposed to severe chronic hyperglycemia showed a limited beta-cell replication and a progressive reduction in beta-cell mass. With normoglycemia, the Tx beta-cells recovered the replicative response to glucose and partially restored the initially Tx beta-cell mass, indicating that normoglycemia, even after long-term hyperglycemia, has a beneficial effect in islet transplantation.
ISSN:0012-1797
1939-327X
0012-1797
DOI:10.2337/diabetes.47.2.192